Head-to-head · Cost-Efficiency Index
WePeptideRx vs MDExam
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
WePeptideRx
Cost-first shoppers who want transparent, all-in per-dose GLP-1 pricing with a named medical director and a real 90-day prepay discount.
Visit WePeptideRxMDExam
Cost-first shoppers who want a lower injectable-semaglutide starting price than the site's own headline claim advertises.
Visit MDExamThe verdict
WePeptideRx takes it, leading the Cost-Efficiency Index 50 to 49. WePeptideRx is a provider-guided telehealth platform selling premixed, ready-to-inject compounded semaglutide ($189-$299/mo across 5 dose tiers) and tirzepatide ($199-$389/mo across 6 dose tiers), both bundled with B12 and glycine. MDExam still earns a C — Cost-first shoppers who want a lower injectable-semaglutide starting price than the site's own headline claim advertises.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs WePeptideRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | WePeptideRx | MDExam |
|---|---|---|
| Cost-Efficiency Index | 50/100 | 49/100 |
| Semaglutide / mo | $189/mo (0.25 mg dose, bundle, plus a separate fee, compounded) | $192/mo (compounded) |
| Tirzepatide / mo | $199/mo (2.5 mg dose, bundle, plus a separate fee, compounded) | $258/mo (compounded) |
| Semaglutide / yr (modeled) | $2,268 | $2,304 |
| Tirzepatide / yr (modeled) | $2,388 | $3,096 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #417 | #423 |
WePeptideRx
50/100Where the value is
- Full dose-by-dose price ladder published with no signup required — 5 tiers for semaglutide, 6 for tirzepatide, each with exact mg dose and matching monthly cost
- Genuinely all-in pricing — consultation, medication, and shipping in one number, no separate visit fee
- Named Medical Director, Hridyesh Nat, MD — a real correction to the current record, which lists this as undisclosed
The tradeoffs
- The lowest advertised monthly rate ($166-176 effective) is NOT the month-to-month price — it requires prepaying a 3-month, $499-529 lump sum
- Pharmacy partner is not named on the pricing page
MDExam
49/100Where the value is
- Injectable semaglutide at $192/mo undercuts the company's own advertised '$225 as low as' floor
- Accepts insurance for eligible patients in addition to cash-pay options
- 100% refund offered if a patient doesn't qualify after evaluation
The tradeoffs
- The site's own headline claim ('priced as low as $225/month') doesn't match either actual product price — tirzepatide at $258/mo is more expensive than the claimed floor, which should make a shopper distrust the headline number generally
- No specific dose is disclosed for either the $192 or $258 figure, making it impossible to know what's actually being compared
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.